全部 标题 作者
关键词 摘要

OALib Journal期刊
ISSN: 2333-9721
费用:99美元

查看量下载量

相关文章

更多...

儿童血源性骨髓炎的抗生素选择、给药途径及持续时间
Antibiotic Selection, Route of Administration, and Duration in Hematogenous Osteomyelitis in Children

DOI: 10.12677/acm.2024.1472160, PP. 1404-1412

Keywords: 儿童,骨髓炎,抗生素,静脉,口服,疗程
Children
, Osteomyelitis, Antibiotics, Intravenous, Oral Administration, Course of Treatment

Full-Text   Cite this paper   Add to My Lib

Abstract:

目的:针对儿童血源性骨髓炎(hematogenous osteomyelitis, HO),最佳治疗方案仍然存在争议,包括抗生素的给药途径、使用疗程和种类选择,本研究将针对上述问题展开系统综述,为儿童血源性骨髓炎的抗生素应用提供建议。方法:对2013~2023年的随机对照试验、队列研究和病例对照研究进行系统综述。结果:我们纳入了18篇文献包括4项随机对照试验,6项队列研究、8项观察性研究;其中4项涉及抗生素使用时间,7项涉及抗生素的应用途径;6项涉及抗生素选择,1项讨论了静脉转为口服的时机。结论:应尽可能缩短静脉抗生素的疗程,提倡口服治疗是更有益的,静脉抗生素疗程推荐2~7天,口服疗程推荐16~20天,优点是更少的并发症、更短的住院时间以及治愈率的提高。对于金黄色葡萄球菌感染的患者抗生素首选β-内酰胺类抗生素(β-lactam, BL),耐甲氧西林金黄色葡萄球(methicillin-resistant Staphylococcus aureus, MRSA)感染患者可采用克林霉素治疗,对于耐克林霉素者推荐采用多肽类抗生素。
Objective: The optimal treatment regimen for hematogenous osteomyelitis (HO) in children, including the choice of route of administration, periodicity, and type of antibiotics, remains controversial, and this study will provide a systematic review of the relevant literature with the expectation of providing recommendations for the use of antibiotics in HO in children. Methods: A systematic review of relevant literature from 2013~2023. Result: We included a total of 18 articles in our review, comprising 4 randomized controlled trials, 6 cohort studies, and 8 observational studies. Among these, 4 studies addressed the duration of antibiotic use, 7 studies examined the route of antibiotic administration, 6 studies focused on antibiotic selection, and 1 study discussed the timing of transitioning from intravenous to oral antibiotics. Conclusion: It is beneficial to minimize the duration of intravenous antibiotic therapy and advocate for oral treatment whenever possible. We recommend a course of 2~7 days for intravenous antibiotics and 16~20 days for oral antibiotics. This approach offers advantages such as fewer complications, shorter hospital stays, and improved cure rates. For patients with Staphylococcus aureus infections, β-lactam (BL) antibiotics (Recommended Benzocillin) are the preferred choice. For methicillin-resistant Staphylococcus aureus (MRSA) infections, treatment with clindamycin is recommended, and for those resistant to clindamycin, peptide antibiotics are recommended.

References

[1]  Peltola, H. and P??kk?nen, M. (2014) Acute Osteomyelitis in Children. New England Journal of Medicine, 370, 352-360.
https://doi.org/10.1056/nejmra1213956
[2]  Howard‐Jones, A.R. and Isaacs, D. (2013) Systematic Review of Duration and Choice of Systemic Antibiotic Therapy for Acute Haematogenous Bacterial Osteomyelitis in Children. Journal of Paediatrics and Child Health, 49, 760-768.
https://doi.org/10.1111/jpc.12251
[3]  Huang, C., Hsieh, R.W., Yen, H., Hsu, T., Chen, C., Chen, Y., et al. (2019) Short-versus Long-Course Antibiotics in Osteomyelitis: A Systematic Review and Meta-Analysis. International Journal of Antimicrobial Agents, 53, 246-260.
https://doi.org/10.1016/j.ijantimicag.2019.01.007
[4]  Sukswai, P., Kovitvanitcha, D., Thumkunanon, V., et al. (2011) Acute Hematogenous Osteomyelitis and Septic Arthritis in Children: Clinical Characteristics and Outcomes Study. The Journal of the Medical Association of Thailand, 94, S209-S216.
[5]  Wu, H., Jia, C., Wang, X., Shen, J., Tan, J., Wei, Z., et al. (2023) The Impact of Methicillin Resistance on Clinical Outcome among Patients with Staphylococcus aureus Osteomyelitis: A Retrospective Cohort Study of 482 Cases. Scientific Reports, 13, Article No. 7990.
https://doi.org/10.1038/s41598-023-35111-w
[6]  Funk, S.S. and Copley, L.A.B. (2017) Acute Hematogenous Osteomyelitis in Children. Orthopedic Clinics of North America, 48, 199-208.
https://doi.org/10.1016/j.ocl.2016.12.007
[7]  Stanitski, C.L. (2004) Changes in Pediatric Acute Hematogenous Osteomyelitis Management. Journal of Pediatric Orthopaedics, 24, 444-445.
https://doi.org/10.1097/01241398-200407000-00016
[8]  Agarwal, A. and Aggarwal, A.N. (2015) Bone and Joint Infections in Children: Acute Hematogenous Osteomyelitis. The Indian Journal of Pediatrics, 83, 817-824.
https://doi.org/10.1007/s12098-015-1806-3
[9]  Batchelder, N. and So, T. (2016) Transitioning Antimicrobials from Intravenous to Oral in Pediatric Acute Uncomplicated Osteomyelitis. World Journal of Clinical Pediatrics, 5, 244-250.
https://doi.org/10.5409/wjcp.v5.i3.244
[10]  Holmes, N., Tong, S., Davis, J. and Hal, S. (2015) Treatment of Methicillin-Resistant Staphylococcus aureus: Vancomycin and Beyond. Seminars in Respiratory and Critical Care Medicine, 36, 17-30.
https://doi.org/10.1055/s-0034-1397040
[11]  Fraimow, H. (2009) Systemic Antimicrobial Therapy in Osteomyelitis. Seminars in Plastic Surgery, 23, 90-99.
https://doi.org/10.1055/s-0029-1214161
[12]  Bouchoucha, S., Gafsi, K., Trifa, M., Saied, W., Ammar, C., Nessib, M.N., et al. (2013) Antibiothérapie intraveineuse des ostéomyélites aigu?s: Traitement long versus court. Archives de Pédiatrie, 20, 464-469.
https://doi.org/10.1016/j.arcped.2013.02.065
[13]  Ossurarson, F., Thors, V. and Haraldsson, A. (2022) Simplified Antibiotic Treatment for Paediatric Osteoarticular Infections Achieved Good Outcomes. Acta Paediatrica, 111, 2188-2194.
https://doi.org/10.1111/apa.16510
[14]  P??kk?nen, M., Kallio, M.J.T., Peltola, H. and Kallio, P.E. (2015) Antibiotic Treatment and Surgery for Acute Hematogenous Calcaneal Osteomyelitis of Childhood. The Journal of Foot and Ankle Surgery, 54, 840-843.
https://doi.org/10.1053/j.jfas.2015.01.006
[15]  Filleron, A., Laurens, M.E., Marin, G., Marchandin, H., Prodhomme, O., Alkar, F., et al. (2019) Short-Course Antibiotic Treatment of Bone and Joint Infections in Children: A Retrospective Study at Montpellier University Hospital from 2009 to 2013. Journal of Antimicrobial Chemotherapy, 74, 3579-3587.
https://doi.org/10.1093/jac/dkz358
[16]  Islam, S., Biary, N. and Wrotniak, B. (2019) Favorable Outcomes with Early Transition to Oral Antibiotics for Pediatric Osteoarticular Infections. Clinical Pediatrics, 58, 696-699.
https://doi.org/10.1177/0009922819829041
[17]  Alcobendas, R., Remesal, A., Murias, S., Nu?ez, E. and Calvo, C. (2018) Outpatients with Acute Osteoarticular Infections Had Favourable Outcomes When They Received Just Oral Antibiotics without Intravenous Antibiotics. Acta Paediatrica, 107, 1792-1797.
https://doi.org/10.1111/apa.14373
[18]  Zaoutis, T., Localio, A.R., Leckerman, K., Saddlemire, S., Bertoch, D. and Keren, R. (2009) Prolonged Intravenous Therapy versus Early Transition to Oral Antimicrobial Therapy for Acute Osteomyelitis in Children. Pediatrics, 123, 636-642.
https://doi.org/10.1542/peds.2008-0596
[19]  Keren, R., Shah, S.S., Srivastava, R., Rangel, S., Bendel-Stenzel, M., Harik, N., et al. (2015) Comparative Effectiveness of Intravenous vs Oral Antibiotics for Postdischarge Treatment of Acute Osteomyelitis in Children. JAMA Pediatrics, 169, 12-128.
https://doi.org/10.1001/jamapediatrics.2014.2822
[20]  Kargel, J.S., Sammer, D.M., Pezeshk, R.A. and Cheng, J. (2018) Oral Antibiotics Are Effective for the Treatment of Hand Osteomyelitis in Children. HAND, 15, 220-223.
https://doi.org/10.1177/1558944718788666
[21]  Roul-Levy, A., Looten, V., Bachy, M., Grimprel, E., Carbajal, R. and Vialle, R. (2016) Oral Ambulatory Treatment of Acute Osteomyelitis in Children. Pediatric Emergency Care, 32, 154-156.
https://doi.org/10.1097/pec.0000000000000725
[22]  Sanchez, M.J., Patel, K., Lindsay, E.A., Tareen, N.G., Jo, C., Copley, L.A., et al. (2022) Early Transition to Oral Antimicrobial Therapy among Children with Staphylococcus aureus Bacteremia and Acute Hematogenous Osteomyelitis. Pediatric Infectious Disease Journal, 41, 690-695.
https://doi.org/10.1097/inf.0000000000003594
[23]  Liu, R.W. and Abaza, H. (2013) Intravenous versus Oral Outpatient Antibiotic Therapy for Pediatric Acute Osteomyelitis. Iowa Orthopedic Journal, 33, 208-212.
[24]  Alcobendas Rueda, R.M., Nú?ez, E., Martín, L., Hernández, M.B., Saavedra-Lozano, J., Udaondo, C., et al. (2022) Oral versus Intravenous Antibiotics for Pediatric Osteoarticular Infection: When and to Whom? Pediatric Infectious Disease Journal, 41, e351-e357.
https://doi.org/10.1097/inf.0000000000003619
[25]  Chou, A.C.C. and Mahadev, A. (2016) The Use of C-Reactive Protein as a Guide for Transitioning to Oral Antibiotics in Pediatric Osteoarticular Infections. Journal of Pediatric Orthopaedics, 36, 173-177.
https://doi.org/10.1097/bpo.0000000000000427
[26]  Nikkhahmanesh, N., Vij, N., Ranade, A.S. and Belthur, M. (2023) Primary Fibular Osteomyelitis in Children: A Systematic Review. Cureus, 15, e41345.
https://doi.org/10.7759/cureus.41345
[27]  Campbell, A.J., Dotel, R., Braddick, M., Britton, P.N., Eisen, D.P., Francis, J.R., et al. (2022) Clindamycin Adjunctive Therapy for Severe Staphylococcus aureus Treatment Evaluation (Cassette)—An Open-Labelled Pilot Randomized Controlled Trial. JAC-Antimicrobial Resistance, 4, dlac014.
https://doi.org/10.1093/jacamr/dlac014
[28]  Bradley, J.S., Arrieta, A.C., Digtyar, V.A., Popejoy, M.W., Grandhi, A., Bokesch, P., et al. (2020) Daptomycin for Pediatric Gram-Positive Acute Hematogenous Osteomyelitis. Pediatric Infectious Disease Journal, 39, 814-823.
https://doi.org/10.1097/inf.0000000000002790
[29]  Minotti, C., Tirelli, F., Guariento, C., Sturniolo, G., Giaquinto, C., Da Dalt, L., et al. (2023) Impact of Guidelines Implementation on Empiric Antibiotic Treatment for Pediatric Uncomplicated Osteomyelitis and Septic Arthritis over a Ten-Year Period: Results of the ELECTRIC Study (Osteomyelitis and Septic Arthritis Treatment in Children). Frontiers in Pediatrics, 11, Article 1135319.
https://doi.org/10.3389/fped.2023.1135319
[30]  Street, M., Puna, R., Huang, M. and Crawford, H. (2015) Pediatric Acute Hematogenous Osteomyelitis. Journal of Pediatric Orthopaedics, 35, 634-639.
https://doi.org/10.1097/bpo.0000000000000332
[31]  Lu, S., Wang, L., Luo, W., Wang, G., Zhu, Z., Liu, Y., et al. (2023) Analysis of the Epidemiological Status, Microbiology, Treatment Methods and Financial Burden of Hematogenous Osteomyelitis Based on 259 Patients in Northwest China. Frontiers in Endocrinology, 13, Article 1097147.
https://doi.org/10.3389/fendo.2022.1097147
[32]  Serrano, E., Ferri, I., Galli, L. and Chiappini, E. (2020) Amoxicillin-Clavulanic Acid Empirical Oral Therapy for the Management of Children with Acute Haematogenous Osteomyelitis. Antibiotics, 9, Article 525.
https://doi.org/10.3390/antibiotics9080525
[33]  McDaniel, L.M., Fiawoo, S., Tamma, P.D. and Same, R.G. (2023) Trimethoprim-Sulfamethoxazole for Pediatric Osteoarticular Infections. Journal of the Pediatric Infectious Diseases Society, 12, 534-539.
https://doi.org/10.1093/jpids/piad076
[34]  Chang, W., Ho, M., Lin, P., Ho, C., Chou, C., Lu, M., et al. (2018) Clinical Characteristics, Treatments, and Outcomes of Hematogenous Pyogenic Vertebral Osteomyelitis, 12-Year Experience from a Tertiary Hospital in Central Taiwan. Journal of Microbiology, Immunology and Infection, 51, 235-242.
https://doi.org/10.1016/j.jmii.2017.08.002
[35]  Thabit, A.K., Fatani, D.F., Bamakhrama, M.S., Barnawi, O.A., Basudan, L.O. and Alhejaili, S.F. (2019) Antibiotic Penetration into Bone and Joints: An Updated Review. International Journal of Infectious Diseases, 81, 128-136.
https://doi.org/10.1016/j.ijid.2019.02.005
[36]  Murphy, J.L., Fenn, N., Pyle, L., Heizer, H., Hughes, S., Nomura, Y., et al. (2016) Adverse Events in Pediatric Patients Receiving Long-Term Oral and Intravenous Antibiotics. Hospital Pediatrics, 6, 330-338.
https://doi.org/10.1542/hpeds.2015-0069
[37]  Lim, R., Mills, C., Burke, A.B., Dhanireddy, S., Beieler, A. and Dillon, J.K. (2021) Are Oral Antibiotics an Effective Alternative to Intravenous Antibiotics in Treatment of Osteomyelitis of the Jaw? Journal of Oral and Maxillofacial Surgery, 79, 1882-1890.
https://doi.org/10.1016/j.joms.2021.04.020
[38]  McMeekin, N., Geue, C., Briggs, A., Rombach, I., Li, H.K., Bejon, P., et al. (2019) Cost-Effectiveness of Oral versus Intravenous Antibiotics (OVIVA) in Patients with Bone and Joint Infection: Evidence from a Non-Inferiority Trial. Wellcome Open Research, 4, 108.
https://doi.org/10.12688/wellcomeopenres.15314.3
[39]  Weichert, S., Sharland, M., Clarke, N.M. and Faust, S.N. (2008) Acute Haematogenous Osteomyelitis in Children: Is There Any Evidence for How Long We Should Treat? Current Opinion in Infectious Diseases, 21, 258-262.
https://doi.org/10.1097/qco.0b013e3283005441
[40]  P??kk?nen, M. and Peltola, H. (2011) Antibiotic Treatment for Acute Haematogenous Osteomyelitis of Childhood: Moving towards Shorter Courses and Oral Administration. International Journal of Antimicrobial Agents, 38, 273-280.
https://doi.org/10.1016/j.ijantimicag.2011.04.007
[41]  Palin, V., Welfare, W., Ashcroft, D.M. and van Staa, T.P. (2021) Shorter and Longer Courses of Antibiotics for Common Infections and the Association with Reductions of Infection-Related Complications Including Hospital Admissions. Clinical Infectious Diseases, 73, 1805-1812.
https://doi.org/10.1093/cid/ciab159
[42]  McNeil, J.C., Joseph, M., Sommer, L.M. and Vallejo, J.G. (2021) The Contemporary Epidemiology, Microbiology and Management of Chronic Osteomyelitis in US Children. Pediatric Infectious Disease Journal, 40, 518-524.
https://doi.org/10.1097/inf.0000000000003067
[43]  Shaikh, N., Umscheid, J., Rizvi, S., Bhatt, P., Vasudeva, R., Yagnik, P., et al. (2021) National Trends of Acute Osteomyelitis and Peripherally Inserted Central Catheters in Children. Hospital Pediatrics, 11, 662-670.
https://doi.org/10.1542/hpeds.2020-005794
[44]  Peltola, H., P??kk?nen, M., Kallio, P. and Kallio, M.J.T. (2010) Short-versus Long-Term Antimicrobial Treatment for Acute Hematogenous Osteomyelitis of Childhood. Pediatric Infectious Disease Journal, 29, 1123-1128.
https://doi.org/10.1097/inf.0b013e3181f55a89
[45]  Gjini, E., Paupério, F.F.S. and Ganusov, V.V. (2020) Treatment Timing Shifts the Benefits of Short and Long Antibiotic Treatment over Infection. Evolution, Medicine, and Public Health, 2020, 249-263.
https://doi.org/10.1093/emph/eoaa033
[46]  Rubinstein, E. and Keynan, Y. (2013) Short-Course Therapy for Severe Infections. International Journal of Antimicrobial Agents, 42, S22-S24.
https://doi.org/10.1016/j.ijantimicag.2013.04.013
[47]  Sze, W.T. and Kong, M.C. (2018) Impact of Printed Antimicrobial Stewardship Recommendations on Early Intravenous to Oral Antibiotics Switch Practice in District Hospitals. Pharmacy Practice, 16, 855.
https://doi.org/10.18549/pharmpract.2018.02.855
[48]  McBride, S., Thurm, C., Gouripeddi, R., Stone, B., Jaggard, P., Shah, S.S., et al. (2018) Comparison of Empiric Antibiotics for Acute Osteomyelitis in Children. Hospital Pediatrics, 8, 280-287.
https://doi.org/10.1542/hpeds.2017-0079
[49]  Lorrot, M., Gillet, Y., Basmaci, R., Bréhin, C., Dommergues, M., Favier, M., et al. (2023) Antibiotic Therapy for Osteoarticular Infections in 2023: Proposals from the Pediatric Infectious Pathology Group (GPIP). Infectious Diseases Now, 53, Article ID: 104789.
https://doi.org/10.1016/j.idnow.2023.104789
[50]  Nisly, S.A., McClain, D.L., Fillius, A.G. and Davis, K.A. (2020) Oral Antibiotics for the Treatment of Gram-Negative Bloodstream Infections: A Retrospective Comparison of Three Antibiotic Classes. Journal of Global Antimicrobial Resistance, 20, 74-77.
https://doi.org/10.1016/j.jgar.2019.07.026

Full-Text

Contact Us

service@oalib.com

QQ:3279437679

WhatsApp +8615387084133